{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:30:28Z","timestamp":1769689828580,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:00:00Z","timestamp":1397174400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-230x-14-74","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T01:02:14Z","timestamp":1397178134000},"source":"Crossref","is-referenced-by-count":41,"title":["Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: A monocentric cohort study in China"],"prefix":"10.1186","volume":"14","author":[{"given":"Zhigang","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongna","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiubo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"1108_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322\/canjclin.55.2.74.","journal-title":"CA Cancer J Clin"},{"key":"1108_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/ijc.2910380608","volume":"38","author":"A Oshima","year":"1986","unstructured":"Oshima A, Hirata N, Ubukata T, Umeda K, Fujimoto L: Evaluation of a mass screening program for stomach cancer with a case\u2013control study design. Int J Cancer. 1986, 38: 829-833. 10.1002\/ijc.2910380608.","journal-title":"Int J Cancer"},{"key":"1108_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ijc.2910600106","volume":"60","author":"A Fukao","year":"1995","unstructured":"Fukao A, Tsubono Y, Tsuji I, Hlsamichi S, Suqahara N, Takano A: The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case\u2013control study. Int J Cancer. 1995, 60: 45-48. 10.1002\/ijc.2910600106.","journal-title":"Int J Cancer"},{"key":"1108_CR4","first-page":"836","volume":"92","author":"Y Abe","year":"1995","unstructured":"Abe Y, Mitsushima T, Nagatani K, Lkuma H, Minamihara Y: Epidemiological evaluation of the protective eff ect for dying of stomach cancer by screening programme for stomach cancer with applying a method of case\u2013control study\u2014a study of an effi cient screening programme for stomach cancer. Nippon Shokakibyo Gakkai Zasshi. 1995, 92: 836-845.","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"key":"1108_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1443-1661.2009.00839.x","volume":"21","author":"K Miki","year":"2009","unstructured":"Miki K, Fujishiro M, Kodashima S, Yahaqi N: Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc. 2009, 21: 78-81. 10.1111\/j.1443-1661.2009.00839.x.","journal-title":"Dig Endosc"},{"key":"1108_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jjco\/hyn017","volume":"38","author":"C Hamashima","year":"2008","unstructured":"Hamashima C, Shibuya D, Yamazaki H, Lnoue K, Fukao A, Saito H, Sobue T: The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2008, 38: 259-267. 10.1093\/jjco\/hyn017.","journal-title":"Jpn J Clin Oncol"},{"key":"1108_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2183\/pjab.87.405","volume":"87","author":"K Miki","year":"2011","unstructured":"Miki K: Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - \u201cABC method\u201d. Proc Jpn Acad Ser B Phys Biol Sci. 2011, 87: 405-414. 10.2183\/pjab.87.405.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"1108_CR8","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1007\/s00018-005-5484-6","volume":"62","author":"L Thim","year":"2005","unstructured":"Thim L, May FE: Structure of mammalian trefoil factors and functional insights. Cell Mol Life Sci. 2005, 62: 2956-2973. 10.1007\/s00018-005-5484-6.","journal-title":"Cell Mol Life Sci"},{"key":"1108_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrm1203","volume":"4","author":"D Taupin","year":"2003","unstructured":"Taupin D, Podolsky DK: Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol. 2003, 4: 721-732. 10.1038\/nrm1203.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1108_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb200108056","volume":"157","author":"C Bossenmeyer-Pouri\u00e9","year":"2002","unstructured":"Bossenmeyer-Pouri\u00e9 C, Kannan R, Ribieras S, Wendling C, Stoll I, Thim L, Tomasetto C, Rio MC: The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J Cell Biol. 2002, 157: 761-770. 10.1083\/jcb200108056.","journal-title":"J Cell Biol"},{"key":"1108_CR11","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1016\/j.lfs.2004.11.014","volume":"76","author":"MW Chan","year":"2005","unstructured":"Chan MW, Chan VY, Leung WK, Chan KK, To KF, Sung JJ, Chan FK: Anti-sense trefoil factor family-3 (intestinal trefoil factor) inhibits cell growth and induces chemosensitivity to adriamycin in human gastric cancer cells. Life Sci. 2005, 76: 2581-2592. 10.1016\/j.lfs.2004.11.014.","journal-title":"Life Sci"},{"key":"1108_CR12","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1053\/j.gastro.2006.01.040","volume":"130","author":"X Yio","year":"2006","unstructured":"Yio X, Diamond M, Zhang JY, Weintein H, Wang LH, Werther L, Itzkowitz S: Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology. 2006, 130: 1696-1706. 10.1053\/j.gastro.2006.01.040.","journal-title":"Gastroenterology"},{"key":"1108_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.peptides.2003.10.019","volume":"25","author":"S Emami","year":"2004","unstructured":"Emami S, Rodrigues S, Rodrigue CM, Le Floch N, Rivat C, Attoub S, Bruyneel E, Gespach C: Trefoil factor family (TFF) peptides and cancer progression. Peptides. 2004, 25: 885-898. 10.1016\/j.peptides.2003.10.019.","journal-title":"Peptides"},{"key":"1108_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10585-005-6615-z","volume":"22","author":"X Yio","year":"2005","unstructured":"Yio X, Zhang JY, Babyatsky M, Chen A, Lin J, Fan QX, Werther JL, Itzkowitz S: Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells. Clin Exp Metastasis. 2005, 22: 157-165. 10.1007\/s10585-005-6615-z.","journal-title":"Clin Exp Metastasis"},{"key":"1108_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.regpep.2004.10.016","volume":"127","author":"VY Chan","year":"2005","unstructured":"Chan VY, Chan MW, Leung WK, Leung PS, Sung JJ, Chan FK: Intestinal trefoil factor promotes invasion in non-tumorigenic Rat-2 fibroblast cell. Regul Pept. 2005, 127: 87-94. 10.1016\/j.regpep.2004.10.016.","journal-title":"Regul Pept"},{"key":"1108_CR16","doi-asserted-by":"publisher","first-page":"18440","DOI":"10.1074\/jbc.M200468200","volume":"277","author":"A Graness","year":"2002","unstructured":"Graness A, Chwieralski CE, Reinhold D, Thim L, Hoffmann W: Protein kinase C and ERK activation are required for TFF-peptide-stimulated bronchial epithelial cell migration and tumor necrosis factor-alpha-induced interleukin-6 (IL-6) and IL-8 secretion. J Biol Chem. 2002, 277: 18440-18446. 10.1074\/jbc.M200468200.","journal-title":"J Biol Chem"},{"key":"1108_CR17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0016-5085(93)90830-6","volume":"104","author":"NA Wright","year":"1993","unstructured":"Wright NA, Poulsom R, Stamp G, Van Noorden S, Sarraf C, Elia G, Ahnen D, Jeffery R, Longcroft J, Pike C: Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology. 1993, 104: 12-20.","journal-title":"Gastroenterology"},{"key":"1108_CR18","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1016\/S0021-9258(18)53305-6","volume":"268","author":"DK Podolsky","year":"1993","unstructured":"Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murque B, Debeaumount M, Sands BE, Mahida YR: Identification of human intestinal trefoil factor, Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem. 1993, 268: 6694-6702.","journal-title":"J Biol Chem"},{"key":"1108_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/(SICI)1096-9896(199709)183:1<30::AID-PATH1085>3.0.CO;2-K","volume":"183","author":"R Poulsom","year":"1997","unstructured":"Poulsom R, Hanby AM, Lalani EN, Hauser F, Hoffmann W, Stamp GW: Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J Pathol. 1997, 183: 30-38. 10.1002\/(SICI)1096-9896(199709)183:1<30::AID-PATH1085>3.0.CO;2-K.","journal-title":"J Pathol"},{"key":"1108_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1053\/hp.2000.6549","volume":"31","author":"DA Devine","year":"2000","unstructured":"Devine DA, High AS, Owen PJ, Poulsom R, Bonass WA: Trefoil factor expression in normal and diseased human salivary glands. Hum Pathol. 2000, 31: 509-515. 10.1053\/hp.2000.6549.","journal-title":"Hum Pathol"},{"key":"1108_CR21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1096\/fasebj.14.9.1126","volume":"14","author":"W Jagla","year":"2000","unstructured":"Jagla W, Wiede A, Dietzmann K, Rutkowski K, Hoffmann W: Co-localization of TFF3 peptide and oxytocin in the human hypothalamus. FASEB J. 2000, 14: 1126-1131.","journal-title":"FASEB J"},{"key":"1108_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/(SICI)1096-9896(200002)190:2<133::AID-PATH518>3.3.CO;2-2","volume":"190","author":"SE Dos Santos","year":"2000","unstructured":"Dos Santos SE, Ulrich M, Doring G, Botaenhart K, Gott P: Trefoil factor family domain peptides in the human respiratory tract. J Pathol. 2000, 190: 133-142. 10.1002\/(SICI)1096-9896(200002)190:2<133::AID-PATH518>3.0.CO;2-B.","journal-title":"J Pathol"},{"key":"1108_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1021\/pr9008817","volume":"9","author":"H Xue","year":"2010","unstructured":"Xue H, L\u00fc B, Zhang J, Wu M, Huang Q, Wu Q, Sheng H, Wu D, Hu J, Lai M: Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res. 2010, 9: 545-555. 10.1021\/pr9008817.","journal-title":"J Proteome Res"},{"key":"1108_CR24","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3892\/or.2012.1627","volume":"27","author":"Y Qu","year":"2012","unstructured":"Qu Y, Yang Y, Ma D, Xiao W: Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer. Oncol Rep. 2012, 27: 1277-1283.","journal-title":"Oncol Rep"},{"key":"1108_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1053\/j.gastro.2011.05.040","volume":"141","author":"S Aikou","year":"2011","unstructured":"Aikou S, Ohmoto Y, Gunji T, Matsuhashi N, Ohtsu H, Miura H, Kubota K, Yamagata Y, Seto Y, Nakajima A, Goldenring JR, Kaminishi M, Nomura S: Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology. 2011, 141: 837-845. 10.1053\/j.gastro.2011.05.040. e1-7","journal-title":"Gastroenterology"},{"key":"1108_CR26","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/sj.bjc.6604546","volume":"99","author":"E Bignotti","year":"2008","unstructured":"Bignotti E, Ravaggi A, Tassi RA, Calza S, Rossi E, Falchetti M, Romani C, Bandiera E, Odicino FE, Pecorelli S, Santin AD: Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas. Br J Cancer. 2008, 99: 768-773. 10.1038\/sj.bjc.6604546.","journal-title":"Br J Cancer"},{"key":"1108_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1158\/1078-0432.CCR-05-1545","volume":"12","author":"EM Vestergaard","year":"2006","unstructured":"Vestergaard EM, Borre M, Poulsen SS, Nex\u00f8 E, T\u00f8rring N: Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. Clin Cancer Res. 2006, 12: 807-812. 10.1158\/1078-0432.CCR-05-1545.","journal-title":"Clin Cancer Res"},{"key":"1108_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1258\/0969141041732184","volume":"11","author":"M Dinis-Ribeiro","year":"2004","unstructured":"Dinis-Ribeiro M, Yamaki G, Miki K, Nex\u00f8 E, T\u00f8rring N: Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen. 2004, 11: 141-147. 10.1258\/0969141041732184.","journal-title":"J Med Screen"},{"key":"1108_CR29","first-page":"490","volume":"38","author":"T Shiga","year":"2000","unstructured":"Shiga T, Nomoto K, Nisizawa M: A study of accuracy of serum pepsinogen method in mass screening and a mass screening using serum pepsinogen. J Gastroenterol Mass Surv. 2000, 38: 490-495.","journal-title":"J Gastroenterol Mass Surv"},{"key":"1108_CR30","first-page":"81","volume":"46","author":"M Yoshihara","year":"1997","unstructured":"Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Tanaka S, Kajiyama G, Shigenobu T: The usefulness of gastric mass screening using serum pepsinogen levels compared with photofl uorography. Hiroshima J Med Sci. 1997, 46: 81-86.","journal-title":"Hiroshima J Med Sci"},{"key":"1108_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/gut.44.5.693","volume":"44","author":"F Kitahara","year":"1999","unstructured":"Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA: Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut. 1999, 44: 693-697. 10.1136\/gut.44.5.693.","journal-title":"Gut"},{"key":"1108_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10120-009-0522-y","volume":"12","author":"S Mizuno","year":"2009","unstructured":"Mizuno S, Kobayashi M, Tomita S, Onoyama M, Habu Y, Inokuchi H, Watanabe Y: Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. Gastric Cancer. 2009, 12: 158-163. 10.1007\/s10120-009-0522-y.","journal-title":"Gastric Cancer"},{"key":"1108_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3748\/wjg.15.853","volume":"15","author":"K Iijima","year":"2009","unstructured":"Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa T: Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol. 2009, 15: 853-859. 10.3748\/wjg.15.853.","journal-title":"World J Gastroenterol"},{"key":"1108_CR34","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ijc.23571","volume":"123","author":"K Yanaoka","year":"2008","unstructured":"Yanaoka K, Oka M, Yoshimura N, Mukoubayashi C, Enomoto S, Iguchi M, Magari H, Utsunomiya H, Tamai H, Arii K, Yamamichi N, Fujishiro M, Takeshita T, Mohara O, Ichinose M: Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels. Int J Cancer. 2008, 123: 917-926. 10.1002\/ijc.23571.","journal-title":"Int J Cancer"},{"key":"1108_CR35","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s00535-011-0396-8","volume":"46","author":"M Kaise","year":"2011","unstructured":"Kaise M, Miwa J, Tashiro J, Ohmoto Y, Morimoto S, Kato M, Urashima M, Ikegami M, Tajiri H: The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk. J Gastroenterol. 2011, 46: 736-745. 10.1007\/s00535-011-0396-8.","journal-title":"J Gastroenterol"},{"key":"1108_CR36","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1158\/1055-9965.EPI-08-0289","volume":"17","author":"M Camorlinga-Ponce","year":"2008","unstructured":"Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahag\u00fan F, Abdo-Francis JM, Aguirre-Garc\u00eda J, Mu\u00f1oz N, Torres J: Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Cancer Epidemiol Biomarkers Prev. 2008, 17: 2498-2504. 10.1158\/1055-9965.EPI-08-0289.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1108_CR37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/path.1711710406","volume":"171","author":"W Muller","year":"1993","unstructured":"Muller W, Borchard F: pS2 protein in gastric carcinoma and normal gastric mucosa: association with clincopathological parameters and patient survival. J Pathol. 1993, 171: 263-269. 10.1002\/path.1711710406.","journal-title":"J Pathol"},{"key":"1108_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1126\/science.274.5285.259","volume":"274","author":"O Lefebvre","year":"1996","unstructured":"Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, Rio MC: Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 1996, 274: 259-262. 10.1126\/science.274.5285.259.","journal-title":"Science"},{"key":"1108_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7150\/ijms.5500","volume":"10","author":"S Im","year":"2013","unstructured":"Im S, Yoo C, Jung JH, Choi HJ, Yoo J, Kang CS: Reduced Expression of TFF1 and Increased Expression of TFF3 in Gastric Cancer: Correlation with Clinicopathological Parameters and Prognosis. Int J Med Sci. 2013, 10: 133-140. 10.7150\/ijms.5500.","journal-title":"Int J Med Sci"},{"key":"1108_CR40","first-page":"655","volume":"21","author":"H Kirikoshi","year":"2002","unstructured":"Kirikoshi H, Katoh M: Expression of TFF1, TFF2 and TFF3 in gastric cancer. Int J Oncol. 2002, 21: 655-659.","journal-title":"Int J Oncol"},{"key":"1108_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10238-012-0210-9","volume":"13","author":"JR Meng","year":"2012","unstructured":"Meng JR, Tang HZ, Zhou KZ, Shen WH, Guo HY: TFF3 and surviving expressions associate with a lower survival rate in gastric cancer. Clin Exp Med. 2012, 13: 297-303.","journal-title":"Clin Exp Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-14-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-14-74\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-14-74","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-14-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:05:01Z","timestamp":1648811101000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-14-74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,11]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-14-74","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,11]]},"article-number":"74"}}